Cite
HARVARD Citation
Verzijl, C. et al. (2020). Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis. Expert opinion on investigational drugs. pp. 125-133. [Online].